EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Proportion and Magnitude of LDL-C Reduction Following CABG with Low-Dose Statin Therapy: A Retrospective Cohort Study

Faiza Agha, Nashit Irfan Aziz, Zeeshan Khan, Muhammad Ibrahim Siddiqui, Marium Nastaeen Sarhandi, Muhammad Qaiser Aziz Khan

Pakistan Heart Journal · 20.09.2026 · 59 (5) · 1582-1588

DOI: 10.47144/phj.v59i5.3322 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pakistan Heart Journal, online erschienen am 20.09.2026. Verfasst von Faiza Agha und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Patients undergoing coronary artery bypass grafting (CABG) require intensive lipid lowering as part of secondary prevention. However, real-world achievement of guideline-recommended ≥50% LDL-C reduction with low-dose statin therapy remains uncertain. Aim of this study was to determine the proportion of patients achieving ≥50% LDL-C reduction and to assess the magnitude of LDL-C reduction over time among post-CABG patients receiving 20 mg dose of statins. Methodology: This retrospective cohort study included 170 post-CABG patients receiving low-dose statin therapy. LDL-C levels were recorded at baseline and at 3, 6, and 12 months. The primary outcome was the proportion of patients achieving ≥50% LDL-C reduction at each time point. Within-subject changes over time were assessed using the Friedman test, with post-hoc pairwise comparisons conducted using Wilcoxon signed-rank tests with Bonferroni correction.

Results

Median LDL-C reduction increased progressively from 16.3% (IQR: 10.7–21.0) at 3 months to 31.0% (IQR: 19.6–35.4) at 6 months and 45.9% (IQR: 25.7–50.6) at 12 months. Differences across time points were statistically significant (Friedman χ² = 423.9, p < 0.001; Kendall’s W = 0.836). No patients achieved ≥50% LDL-C reduction at 3 or 6 months, whereas 28.8% (95% CI: 22.5–36.1) achieved this target at 12 months. Mean LDL-C declined from 152.9 ± 20.6 mg/dL at baseline to 94.7 ± 27.6 mg/dL at 12 months.

Conclusion

LDL-C reduction following CABG with low-dose statins is progressive over time; however, achievement of ≥50% reduction is limited within the first year. These findings highlight the need for closer monitoring and potential treatment intensification.

Zitieren

APA

Agha, F., Aziz, N. I., Khan, Z., Siddiqui, M. I., Sarhandi, M. N., & Khan, M. Q. A. (2026). Proportion and Magnitude of LDL-C Reduction Following CABG with Low-Dose Statin Therapy: A Retrospective Cohort Study. Pakistan Heart Journal, 59(5), 1582-1588. https://doi.org/10.47144/phj.v59i5.3322

Vancouver

Agha F, Aziz NI, Khan Z, Siddiqui MI, Sarhandi MN, Khan MQA. Proportion and Magnitude of LDL-C Reduction Following CABG with Low-Dose Statin Therapy: A Retrospective Cohort Study. Pakistan Heart Journal. 2026;59(5):1582-1588. doi:10.47144/phj.v59i5.3322

BibTeX
@article{Agha2026,
  author = {Agha, Faiza and Aziz, Nashit Irfan and Khan, Zeeshan and Siddiqui, Muhammad Ibrahim and Sarhandi, Marium Nastaeen and Khan, Muhammad Qaiser Aziz},
  title = {Proportion and Magnitude of LDL-C Reduction Following CABG with Low-Dose Statin Therapy: A Retrospective Cohort Study},
  journal = {Pakistan Heart Journal},
  year = {2026},
  volume = {59},
  number = {5},
  pages = {1582--1588},
  doi = {10.47144/phj.v59i5.3322}
}
Kostenlos starten →